Overview

Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage cancer cells. Bone marrow transplantation may allow doctors to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Randomized phase III trial to study the effectiveness of chemotherapy and radiation therapy plus bone marrow transplantation in treating patients who have aggressive non-Hodgkin's lymphoma.

Phase:

Phase 3

Details

Lead Sponsor:

Scotland and Newcastle Lymphoma Group

Treatments:

Bleomycin
Carmustine
Cyclophosphamide
Cytarabine
Doxorubicin
Etoposide
Liposomal doxorubicin
Melphalan
Prednisolone
Vincristine